PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -100.0% | 27 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $16,299,000 | -18.1% | 834,967 | +11.8% | 0.12% | -2.4% |
| Q3 2018 | $19,892,000 | -30.1% | 746,968 | -0.8% | 0.12% | -31.9% |
| Q2 2018 | $28,451,000 | +14.4% | 753,266 | -1.1% | 0.18% | +15.9% |
| Q1 2018 | $24,864,000 | – | 761,290 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |